 |
PDBsum entry 4n2h
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Protein arginine deiminase 2 binds calcium in an ordered fashion: implications for inhibitor design.
|
 |
|
Authors
|
 |
D.J.Slade,
P.Fang,
C.J.Dreyton,
Y.Zhang,
J.Fuhrmann,
D.Rempel,
B.D.Bax,
S.A.Coonrod,
H.D.Lewis,
M.Guo,
M.L.Gross,
P.R.Thompson.
|
 |
|
Ref.
|
 |
Acs Chem Biol, 2015,
10,
1043-1053.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Protein arginine deiminases (PADs) are calcium-dependent histone-modifying
enzymes whose activity is dysregulated in inflammatory diseases and cancer. PAD2
functions as an Estrogen Receptor (ER) coactivator in breast cancer cells via
the citrullination of histone tail arginine residues at ER binding sites.
Although an attractive therapeutic target, the mechanisms that regulate PAD2
activity are largely unknown, especially the detailed role of how calcium
facilitates enzyme activation. To gain insights into these regulatory processes,
we determined the first structures of PAD2 (27 in total), and through
calcium-titrations by X-ray crystallography, determined the order of binding and
affinity for the six calcium ions that bind and activate this enzyme. These
structures also identified several PAD2 regulatory elements, including a calcium
switch that controls proper positioning of the catalytic cysteine residue, and a
novel active site shielding mechanism. Additional biochemical and
mass-spectrometry-based hydrogen/deuterium exchange studies support these
structural findings. The identification of multiple intermediate calcium-bound
structures along the PAD2 activation pathway provides critical insights that
will aid the development of allosteric inhibitors targeting the PADs.
|
 |
|
|
|
|
 |